Stifel upgraded Danaher (DHR) to Buy from Hold with a $260 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DHR:
- Beckman Coulter announces FDA clearance of DxC 500i Clinical Analyzer
- Danaher placed on ‘positive catalyst watch’ at Citi
- Unusually active option classes on open February 26th
- Early notable gainers among liquid option names on February 21st
- Danaher: Strategic Cost Savings Initiative and Resilient Management Underpin Buy Rating